ProCE Banner Activity

CDK4/6 Inhibitors in HR+/HER2- Breast Cancer: Addressing Barriers to Their Optimal Use

Slideset

To access the downloadable PowerPoint slide set on CDK4/6 inhibitors in HR+/HER2- breast cancer, please click the download button.

Released: April 22, 2022

Expiration: April 21, 2023

Share

Acknowledgement

This activity is supported by an educational grant from Lilly.

Supporters

Lilly

Additional Information

Program Medium

This program has been made available online.